| Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532649 |
NSE Symbol : NECLIFE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE023H01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 29.98 |
Market Cap(₹Cr) : 213.49 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 241.75 | 222.89 | 256.69 |
| Net Sales | 0.00 | 0.00 | 1,684.08 | 1,523.67 | 1,668.23 |
| Other Income | 9.29 | 1.88 | 14.58 | 43.18 | 11.32 |
| Stock Adjustments | 0.00 | 0.00 | 40.21 | 41.64 | -14.97 |
| Total Income | 9.29 | 1.88 | 1,738.87 | 1,608.49 | 1,664.58 |
| EXPENDITURE : | |||||
| Raw Materials | 0.00 | 0.00 | 1,242.45 | 1,200.84 | 1,207.32 |
| Power and Fuel Cost | 0.10 | 0.05 | 129.52 | 127.39 | 101.41 |
| Other Manufacturing Expenses | 0.01 | 0.00 | 55.30 | 44.88 | 45.09 |
| Selling and Administration Expenses | 4.39 | 0.05 | 61.38 | 61.01 | 66.82 |
| Miscellaneous Expenses | 290.85 | 114.38 | 2.37 | 1.32 | 1.90 |
| Employee Benefit Expenses | 0.89 | 0.09 | 81.71 | 75.14 | 71.91 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -286.94 | -112.69 | 166.13 | 97.91 | 170.13 |
| Interest | 36.13 | 0.00 | 87.14 | 79.48 | 78.81 |
| Gross Profit | -323.07 | -112.69 | 78.99 | 18.43 | 91.32 |
| Depreciation | 0.34 | 0.62 | 60.72 | 59.12 | 56.97 |
| Profit Before Tax | -323.41 | -113.31 | 18.27 | -40.69 | 34.35 |
| Current Tax | -30.53 | 0.38 | 13.27 | -18.24 | 9.03 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -292.89 | -113.68 | 5.00 | -22.46 | 25.32 |
| Extraordinary Items | -52.25 | 0.04 | 0.18 | 40.51 | 9.41 |
| Adjusted Net Profit | -240.64 | -113.72 | 4.82 | -62.97 | 15.91 |
| Adjustment below Net Profit | 0.08 | 0.54 | -0.34 | 0.19 | 0.81 |
| Profit/Loss Balance carried down | 590.79 | 703.93 | 699.27 | 721.54 | 695.41 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 294.98 | 590.79 | 703.93 | 699.27 | 721.54 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -15.08 | -5.07 | 0.22 | -1.00 | 1.13 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 29.98 | 42.63 | 47.68 | 47.47 | 48.46 |
| Book Value(Adj)-Unit Curr | 29.98 | 42.63 | 47.68 | 47.47 | 48.46 |
